Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.